Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: Analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study

Nicola Fazio, Dan Granberg, Ashley Grossman, Stephen Saletan, Judith Klimovsky, Ashok Panneerselvam, Edward M. Wolin

Research output: Contribution to journal › Article › peer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: Analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences